Google.org

Google.org is a philanthropic arm of Google, a multinational technology company. It funds and supports nonprofits globally, providing them with funding, tools, and volunteers. Google.org has committed approximately $100 million annually to these efforts, aiming to extend the reach of innovative nonprofits and create lasting global impact.

Ekta Aggarwal

Principal Account Manager

John Bell

CEO-Founder

Sumiran Das

Growth Equity Investor at Google Capital

Jacquelline Fuller

President

Raj Gajwani

Director, Orion Wifi @ Google Area 120

Carletta Higginson

Director, Global Head of Music Publishing

Rahul Jain

Lead, Venture Capital and Startups - Google Cloud

Aftab Jutt

CEO

Sushrut Karanjkar

Director

Jess Kuizon

CEO

Bibiana Leite

Director, Scaled Partnerships

Anthony Nakache

Managing Director, Google MENA

David Reshef

Venture Partner

Issi Rozen

Venture Partner

Philipp Schindler

Senior Vice President and Chief Business Officer

Andrew R. Whalley

Director, Chrome Security

Andy Wheeler

General Partner

LightRoom Premium Mod APK Download Android

CEO

Co khi Nhan Do

CEO

Past deals in Personal Health

Allara Health

Series B in 2025
Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.

Jacaranda Health

Grant in 2024
Jacaranda Health is a medical services provider in Kenya, specializing in maternal and child health. It operates clinics in underserved, peri-urban areas, offering high-quality, affordable care, including maternity services, general healthcare, and nursing mentorship. Jacaranda's services are designed to be patient-centered and cost a fifth of what's charged by other private hospitals. Notably, the company has achieved a zero maternal mortality rate, significantly lower than Kenya's national average of 400 per 100,000 births. Additionally, Jacaranda engages in research and innovation to improve its services and develop new tools for low-income women.

Midi Health

Series B in 2024
Midi Health is a virtual care clinic dedicated to addressing the health needs of women, particularly those experiencing menopause and related conditions. The clinic specializes in treating issues such as depression, gynecological cancers, and menstrual problems. Its clinical platform provides personalized treatment protocols crafted by clinicians with expertise in female midlife health. Midi Health utilizes specialized at-home labs, prescription medications, supplements, and lifestyle coaching to support women in managing the challenges they encounter during critical stages of their lives and careers. By focusing on a holistic approach, Midi Health aims to empower women to achieve better health outcomes.

Oula Health

Series B in 2024
Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Signos

Series B in 2023
Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Allara Health

Series A in 2023
Allara Health is a healthcare provider specializing in virtual care for women facing complex, chronic health conditions, particularly polycystic ovary syndrome (PCOS). The company offers a comprehensive program that connects patients with medical providers and registered dietitians through virtual appointments. Allara's services include holistic care, diagnostic testing, and prescriptions, along with personalized guidance on dietary and lifestyle changes. By leveraging technology, the platform enables women to efficiently manage their health, allowing for improved tracking and treatment of their conditions.

Midi Health

Series A in 2023
Midi Health is a virtual care clinic dedicated to addressing the health needs of women, particularly those experiencing menopause and related conditions. The clinic specializes in treating issues such as depression, gynecological cancers, and menstrual problems. Its clinical platform provides personalized treatment protocols crafted by clinicians with expertise in female midlife health. Midi Health utilizes specialized at-home labs, prescription medications, supplements, and lifestyle coaching to support women in managing the challenges they encounter during critical stages of their lives and careers. By focusing on a holistic approach, Midi Health aims to empower women to achieve better health outcomes.

Jacaranda Health

Grant in 2023
Jacaranda Health is a medical services provider in Kenya, specializing in maternal and child health. It operates clinics in underserved, peri-urban areas, offering high-quality, affordable care, including maternity services, general healthcare, and nursing mentorship. Jacaranda's services are designed to be patient-centered and cost a fifth of what's charged by other private hospitals. Notably, the company has achieved a zero maternal mortality rate, significantly lower than Kenya's national average of 400 per 100,000 births. Additionally, Jacaranda engages in research and innovation to improve its services and develop new tools for low-income women.

IDinsight with Reach Digital Health

Grant in 2023
IDinsight with Reach Digital Health developed a natural language-enabled question-and-answer service for pregnant moms that delivers responses to questions as well as important health information.

Syrona Health

Seed Round in 2022
Syrona Health is a digital health company focused on personalized gynecological care throughout various life stages, including menstrual health, fertility, parenthood, and menopause. It offers a virtual health support platform that integrates software and hardware to enhance gynecological health outcomes. The company's solutions address conditions such as endometriosis, polycystic ovary syndrome (PCOS), and gynecological cancers, enabling women to monitor their health independently. Syrona Health also provides at-home clinical testing and online counseling, allowing women to manage their gynecological health proactively without relying on lengthy clinic visits for diagnostics.

Mirvie

Series B in 2022
Mirvie is a biotechnology company specializing in non-invasive tests for maternal-fetal health, aimed at enhancing the safety of pregnancy. Founded in 2018 by Maneesh Jain and based in South San Francisco, California, Mirvie provides predictive diagnostic tools that deliver actionable insights to expectant mothers and families. Its medical diagnostic platform enables healthcare practitioners to identify at-risk pregnancies, facilitating timely interventions and therapeutic approaches to improve pregnancy outcomes. Through its innovative solutions, Mirvie seeks to empower families with critical information, ensuring a safer pregnancy experience.

Brightline

Series C in 2022
Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.

Elly

Venture Round in 2022
Elly Health Inc. specializes in developing audio companion software designed for patients, healthcare providers, and organizations. Founded in 2019 and headquartered in Los Angeles, California, the company offers Elly, an innovative empathetic audio companion specifically tailored for individuals managing chronic diseases. This technology aims to motivate and support patients by connecting them with expert advice and community contributions, thereby enhancing their healthcare experience. Elly Health Inc. stands out as a pioneer in the realm of empathetic digital health solutions.

Found

Series B in 2021
Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.

Signos

Series A in 2021
Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Patina Health

Series A in 2021
Patina Health operates a specialized primary care model focused on improving healthcare outcomes for older adults. Their approach prioritizes personalization, accessibility, and family involvement, aiming to enhance the aging experience by addressing the unique needs of this demographic.

Sprinter Health

Series A in 2021
Sprinter Health is a mobile healthcare company that provides on-demand services by sending full-time nurses and phlebotomists to patients' homes. The company aims to improve access to preventive care through modern house calls, enhancing the patient experience and satisfaction. By utilizing a cost-effective hybrid care model, Sprinter Health connects patients with essential healthcare services, allowing them to receive quality care in the comfort of their own homes. This approach not only improves health outcomes but also addresses the growing demand for convenient and accessible healthcare solutions.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a genomic medicine delivery company based in South San Francisco, California, established in 2016. It operates a technology platform known as Genome Care Delivery, which connects individuals and healthcare providers with genetic specialists to facilitate virtual genetic consultations. The company focuses on various areas of clinical care, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacogenomics. By providing expert genetic assessments and personalized clinical action plans, Genome Medical helps patients understand their genetic risks and make informed treatment decisions. Additionally, the company supports healthcare providers in navigating the growing field of genetics, enhancing disease diagnosis, and improving patient care while aiming to reduce overall healthcare costs.

CourMed

Seed Round in 2021
CourMed is a private client health services company that specializes in delivering healthcare products and services directly to clients' homes, offices, or other locations. The company offers a unique concierge service model, which emphasizes personalized and convenient health and wellness solutions. Clients can choose between two membership options: Purple, which ensures concierge visits within 3-5 days, and Platinum, which guarantees same day or next day visits. CourMed's offerings include in-home consultations, patient advocacy, regenerative therapies, and DNA-personalized supplements. Additionally, the company utilizes software to track delivery processes, ensuring proof of delivery, confirmation signatures, and product images for clients. This innovative approach allows CourMed to provide accessible emergency services and a high level of customer satisfaction.

Brightline

Series B in 2021
Brightline, Inc. is a pediatric behavioral health care provider that focuses on supporting children and their families through innovative technology and integrated care. Established in 2019 and headquartered in Palo Alto, California, Brightline offers a range of services including behavioral therapy, psychiatry, medication support, speech-language therapy, and occupational therapy. The company emphasizes virtual behavioral health services and a collaborative care team to address the diverse needs of children at various developmental stages. Originally named Emilio Health, Inc., the company rebranded to Brightline in May 2020, reflecting its commitment to delivering accessible and comprehensive behavioral health solutions.

Favor

Series B in 2021
Favor is a direct-to-consumer service for women and people who menstruate, that’s on a mission to make healthcare more accessible by building a digital health platform that closes racial, gender and socioeconomic gaps in our healthcare system. Favor is the easiest way for women and people who menstruate to address their sexual health and overall wellbeing, regardless of where they live or if they’re covered by health insurance–making Favor an affordable, accessible telehealth provider.

Found

Series A in 2021
Found is dedicated to improving people’s overall wellbeing by making evidence-based weight loss accessible and affordable. The company was founded in 2019 and is headquartered in San Francisco, California, United States.

Elly

Venture Round in 2020
Elly Health Inc. specializes in developing audio companion software designed for patients, healthcare providers, and organizations. Founded in 2019 and headquartered in Los Angeles, California, the company offers Elly, an innovative empathetic audio companion specifically tailored for individuals managing chronic diseases. This technology aims to motivate and support patients by connecting them with expert advice and community contributions, thereby enhancing their healthcare experience. Elly Health Inc. stands out as a pioneer in the realm of empathetic digital health solutions.

Alerje

Grant in 2020
Alerje, Inc. is a Detroit-based company focused on enhancing the quality of life for individuals with food allergies. Founded in 2015, Alerje has developed an innovative emergency medicine and digital oral immunotherapy management platform. Central to its offerings is an epinephrine auto-injector that conveniently fits into a smartphone case, promoting better adherence and alert management for users. The company also provides a mobile application that allows users to create personalized food allergy profiles, share these profiles with caregivers and medical professionals, and filter recipes based on allergen information. Additionally, the app includes features for scanning grocery items to identify potential allergens, thus aiding families and healthcare providers in making informed dietary choices. Alerje's platform is validated by the National Science Foundation and aims to improve emergency response and overall management of food allergies.

Fitbit

Acquisition in 2019
Fitbit is a company focused on promoting healthier lifestyles through its digital health and fitness devices. It develops the Fitbit Tracker, a compact wireless wearable sensor that automatically monitors various aspects of a user's activities, including calories burned, sleep quality, steps taken, and distance traveled. This device continuously collects data while worn throughout the day, which is then wirelessly uploaded to a dedicated website. Users can access their information to track progress toward personal health goals, engage with a motivational interface, and share achievements with friends, family, and co-workers. Additionally, the platform allows users to manually log nutrition, weight, and other health metrics, providing a comprehensive overview of their well-being. By automating health data collection and offering an engaging user experience, Fitbit aims to simplify the journey toward a healthier lifestyle.

Favor

Series B in 2019
Favor is a direct-to-consumer service for women and people who menstruate, that’s on a mission to make healthcare more accessible by building a digital health platform that closes racial, gender and socioeconomic gaps in our healthcare system. Favor is the easiest way for women and people who menstruate to address their sexual health and overall wellbeing, regardless of where they live or if they’re covered by health insurance–making Favor an affordable, accessible telehealth provider.

HelpMum

Grant in 2018
HelpMum is a digital social enterprise operating in Africa, focused on reducing maternal and infant mortality. It offers a mobile platform that includes a vaccination tracker and AI-driven reminders, helping parents adhere to immunization schedules. Additionally, HelpMum distributes clean birth kits to underserved areas, further supporting maternal and infant health. The company leverages mobile technology and low-cost innovation to tackle these critical health challenges.

Senosis Health

Acquisition in 2017
Senosis Health is a startup focused on mobile health monitoring. The company develops applications that utilize the capabilities of smartphones, such as the accelerometer, microphone, flash, and camera, to measure, diagnose, and manage diseases. Their solutions include monitoring lung health and hemoglobin counts, providing users with accessible healthcare tools directly on their mobile devices.

23andMe

Series E in 2015
23andMe, Inc. is a consumer genetics and research company headquartered in Sunnyvale, California, founded in 2006. It specializes in providing direct-to-consumer personal genome services through home-based saliva collection kits. The company offers a range of services, including Health + Ancestry, which provides insights into ancestry, traits, and health, and Ancestry + Traits, which details ancestry breakdown and various trait reports. 23andMe aims to help individuals understand their genetic makeup, enabling users to explore their ancestry, genealogy, and inherited traits. Additionally, the company markets its services to researchers and scientists, offering categorized and searchable genetic data. With a focus on consumer and research services, 23andMe is positioned within the rapidly growing biotech and healthcare sectors, contributing to the understanding of genetics and its implications for health.

Walker and Company Brands

Series B in 2015
Walker and Company Brands is a manufacturer of health and beauty products tailored for both men and women, with a focus on serving the needs of people of color. The company offers a range of products, including shaving kits and hair care collections specifically designed for coarse and curly hair. Committed to consumer-centricity, Walker and Company aims to reinvent how its community learns about, purchases, and enjoys health and beauty products. By developing and testing products that address the unique needs of its customers, the company emphasizes exceptional customer service and a straightforward shopping experience.

Hello Heart

Venture Round in 2015
Hello Heart Inc., established in 2013 and headquartered in Redwood City, California, specializes in developing digital health solutions. Its flagship product is Hello Heart, a mobile application designed to empower individuals to manage their heart health effectively. The app enables users to track their blood pressure and weight, providing real-time personalized tips based on clinical guidelines. Employers can also utilize this platform to proactively manage employee health risks associated with high blood pressure, fostering behavior change and preventing serious health issues.

Spruce Health

Series A in 2015
Spruce Health, Inc. is a healthcare technology company based in San Francisco, California, established in 2013. It offers an interactive mobile application that facilitates communication between patients and dermatologists for the diagnosis and treatment of various skin conditions, including acne, eczema, psoriasis, and male hair loss. The company aims to improve the healthcare experience by reducing wait times and simplifying the process of accessing medical care. Spruce Health is dedicated to enhancing the patient-physician relationship and ensuring quality healthcare is accessible at any time and from any location. Through its platform, Spruce Health seeks to provide affordable healthcare solutions and increase patient satisfaction while improving practice efficiency for healthcare providers.

Rise

Seed Round in 2013
Rise offers affordable personal diet coaching through a mobile platform that connects users with expert nutrition coaches. By understanding individual tastes and lifestyles, these coaches provide tailored guidance and accountability to help clients achieve their fitness goals. The service is designed to be accessible, with costs as low as $1 per day, making personalized nutrition support more attainable for a wider audience.

FitStar (acq. by Fitbit)

Series A in 2013
We are a passionate team creating a next-generation digital fitness platform and are on a mission to craft products that inspire millions of people to get fit and live healthier lives. Along with our new family at Fitbit, we design health and fitness products and experiences that fit seamlessly into everyday life to help millions of people achieve their goals. We provide the workouts, insights and encouragement to make smart choices to show how small, everyday changes add up to big results.

23andMe

Series D in 2012
23andMe, Inc. is a consumer genetics and research company headquartered in Sunnyvale, California, founded in 2006. It specializes in providing direct-to-consumer personal genome services through home-based saliva collection kits. The company offers a range of services, including Health + Ancestry, which provides insights into ancestry, traits, and health, and Ancestry + Traits, which details ancestry breakdown and various trait reports. 23andMe aims to help individuals understand their genetic makeup, enabling users to explore their ancestry, genealogy, and inherited traits. Additionally, the company markets its services to researchers and scientists, offering categorized and searchable genetic data. With a focus on consumer and research services, 23andMe is positioned within the rapidly growing biotech and healthcare sectors, contributing to the understanding of genetics and its implications for health.

FitStar (acq. by Fitbit)

Seed Round in 2012
We are a passionate team creating a next-generation digital fitness platform and are on a mission to craft products that inspire millions of people to get fit and live healthier lives. Along with our new family at Fitbit, we design health and fitness products and experiences that fit seamlessly into everyday life to help millions of people achieve their goals. We provide the workouts, insights and encouragement to make smart choices to show how small, everyday changes add up to big results.

23andMe

Series C in 2010
23andMe, Inc. is a consumer genetics and research company headquartered in Sunnyvale, California, founded in 2006. It specializes in providing direct-to-consumer personal genome services through home-based saliva collection kits. The company offers a range of services, including Health + Ancestry, which provides insights into ancestry, traits, and health, and Ancestry + Traits, which details ancestry breakdown and various trait reports. 23andMe aims to help individuals understand their genetic makeup, enabling users to explore their ancestry, genealogy, and inherited traits. Additionally, the company markets its services to researchers and scientists, offering categorized and searchable genetic data. With a focus on consumer and research services, 23andMe is positioned within the rapidly growing biotech and healthcare sectors, contributing to the understanding of genetics and its implications for health.

23andMe

Series B in 2009
23andMe, Inc. is a consumer genetics and research company headquartered in Sunnyvale, California, founded in 2006. It specializes in providing direct-to-consumer personal genome services through home-based saliva collection kits. The company offers a range of services, including Health + Ancestry, which provides insights into ancestry, traits, and health, and Ancestry + Traits, which details ancestry breakdown and various trait reports. 23andMe aims to help individuals understand their genetic makeup, enabling users to explore their ancestry, genealogy, and inherited traits. Additionally, the company markets its services to researchers and scientists, offering categorized and searchable genetic data. With a focus on consumer and research services, 23andMe is positioned within the rapidly growing biotech and healthcare sectors, contributing to the understanding of genetics and its implications for health.

Navigenics

Venture Round in 2007
Navigenics, Inc. specializes in personalized genetics testing and health counseling services aimed at educating individuals and their physicians about genetic predispositions. The company provides genetic information and analysis to empower clients to take proactive measures to prevent disease, facilitate early diagnosis, and effectively manage health conditions. Navigenics delivers its services through a network of medical centers and physicians, as well as employer wellness programs at leading corporations. By motivating individuals to act on their genetic insights, Navigenics seeks to enhance overall health outcomes and reduce the impact of potential diseases.

23andMe

Series A in 2007
23andMe, Inc. is a consumer genetics and research company headquartered in Sunnyvale, California, founded in 2006. It specializes in providing direct-to-consumer personal genome services through home-based saliva collection kits. The company offers a range of services, including Health + Ancestry, which provides insights into ancestry, traits, and health, and Ancestry + Traits, which details ancestry breakdown and various trait reports. 23andMe aims to help individuals understand their genetic makeup, enabling users to explore their ancestry, genealogy, and inherited traits. Additionally, the company markets its services to researchers and scientists, offering categorized and searchable genetic data. With a focus on consumer and research services, 23andMe is positioned within the rapidly growing biotech and healthcare sectors, contributing to the understanding of genetics and its implications for health.

Sprinter Health

Sprinter Health is a mobile healthcare company that provides on-demand services by sending full-time nurses and phlebotomists to patients' homes. The company aims to improve access to preventive care through modern house calls, enhancing the patient experience and satisfaction. By utilizing a cost-effective hybrid care model, Sprinter Health connects patients with essential healthcare services, allowing them to receive quality care in the comfort of their own homes. This approach not only improves health outcomes but also addresses the growing demand for convenient and accessible healthcare solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.